How to license a medical device technology from SCTIMST
SCTIMST technology transfer explained: how its EoI calls work, which devices it has offered, licence terms, the documents to send and CDSCO steps after signing.
Part of the guide Licensing technology from Indian institutions: the complete guide for companies
SCTIMST in Thiruvananthapuram licenses medical device technologies developed at its Biomedical Technology Wing through Expression of Interest calls. Companies, including startups, submit Annexures 1, 2 and 3 as a signed hard copy. Licences are exclusive or non-exclusive, for an upfront lump-sum fee plus annual royalties that vary by product. Its Technology Business Division handles enquiries.
If you make medical devices in India, the Sree Chitra Tirunal Institute for Medical Sciences and Technology (SCTIMST) in Thiruvananthapuram is one institute worth watching closely. It is an Institute of National Importance under the Department of Science and Technology, and its Biomedical Technology (BMT) Wing has developed implants, cardiac devices and lab products that it offers to industry.
The process is simple on paper and slow in practice. You respond to a call, send a signed hard copy, get shortlisted, then negotiate. This guide covers how the calls work, what SCTIMST has offered in recent years, what the licence terms look like, and the regulatory work you take on after you sign.
How does SCTIMST offer technologies to industry?
SCTIMST publishes Expression of Interest (EoI) calls on the Technologies for Transfer pages of its BMT Wing. I read four of these calls, from 2019, 2022, 2023 and 2024. They follow the same pattern:
- SCTIMST says it is offering technologies for licensing to enterprises, including startups, for scale-up and commercialisation.
- Technologies are at different readiness levels, "such as proof of concept, pre-clinical / clinical evaluation."
- Licences may be exclusive or non-exclusive.
- Payment is "a combination of up-front lump sum fee and annual royalties," and terms "will vary from product to product."
- You submit a proposal in the given format, Annexures 1, 2 and 3, naming the technology you want.
- The proposal goes as a signed hard copy to the Head, BMT Wing, SCTIMST, Poojapura, Thiruvananthapuram 695012, by 12 noon on the last date.
The Technology Business Division handles questions and can arrange visits and detailed discussions. Its contact on the calls is tbd@sctimst.ac.in, phone 0471-2520309/308.
Note the hard copy. SCTIMST's calls asked for signed paper, so post or courier it early enough to reach Thiruvananthapuram before noon on the closing day.
From an SCTIMST call to a signed licence
Which technologies has SCTIMST offered?
The archived calls give a good sense of the range. The table shows three of them; other calls, such as one in February 2023, offered further products. All of these windows have closed, so treat the list as an example of what comes up, and check the live page for current calls.
| Call (last date) | Technologies offered | What the call says |
|---|---|---|
| 15 March 2022 | Implantable micro infusion pump; bioink for 3D bioprinting | Pump: Class D, TRL 4, Indian patent application 202041045741 and design registration 341393-001. Bioink: one Indian application, lab batch of 200 g a month |
| 31 December 2023 | Bioprosthetic heart valve (bovine pericardium); TiN coated coronary stent system; automatic contrast injector; automated trolley (e-Drive) | Readiness not given per item |
| 15 December 2024 | Mitral annuloplasty ring; intracranial electrodes for electrocorticography up to 15 days; isolation and purification of plasma proteins (fibrinogen, thrombin, intravenous immunoglobulin, albumin) | Readiness not given per item |
The 2022 pump call is the most detailed one I read, and it shows what a good listing tells you. It lists the standards the device was tested against (ISO 14708-4 and ISO 10993 for biocompatibility) and the tests done, such as flow, accuracy, septum puncture and durability. It also lists what the licensee must do: preclinical studies, drug interaction studies, clinical trials, packaging and regulatory submissions.
That last list matters more than the device name. At TRL 4 you are buying a well-tested lab design and taking on years of work and cost to reach the market. Our guide to TRL for medical devices maps those remaining steps.
SCTIMST has also asked companies to propose industry-driven products. Its 2019 call invited proposals in cardiovascular devices, neuroprosthetic devices, orthotics and rehabilitation, in vitro diagnostics, hard tissue devices, biologics, regenerative technology, point-of-care devices and connected health, with joint development considered case by case.
What should your EoI contain?
The annexure formats come with each call, so follow them exactly. Whatever the form asks, a strong proposal answers four questions clearly.
| Question the institute is really asking | What to show |
|---|---|
| Can you make this device to medical grade? | Existing products, clean room or controlled area, ISO 13485 or equivalent quality system |
| Can you take it through regulation? | Current CDSCO or state licences, regulatory staff or consultant, past approvals |
| Can you fund the remaining work? | Budget for clinical work, testing and tooling, and where the money comes from |
| Can you sell it? | Your hospital channels, distributors and export plans |
A two-page plan that maps the call's "industry responsibilities" to named people and a budget does more than a glossy company profile. If the call lists preclinical and clinical evaluation as your job, say who will run them and roughly when.
What are the licence terms like?
The calls say only "upfront lump sum fee and annual royalties" and "exclusive or non-exclusive". Everything else is negotiated. Points I would put on the table:
- Exclusivity and its scope: by product, by territory or by field of use. See sole vs exclusive licence.
- What the upfront fee buys: drawings, process documents, training days, a set number of support visits.
- How royalty is calculated, especially the definition of net sales. Royalty base explained shows how small wording changes move the bill.
- Who files and pays for the patent and design from here, and in which countries.
- Diligence milestones: what happens if regulatory approval takes longer than planned.
- Improvements made by either side after signing.
Illustration with invented figures. Say a company licenses a Class C implant non-exclusively for an upfront fee of ₹15 lakh and a 3% royalty on net sales. It sells 2,000 units in year three at a net price of ₹40,000.
| Item | Amount |
|---|---|
| Net sales in year three (2,000 × ₹40,000) | ₹8,00,00,000 |
| Royalty at 3% | ₹24,00,000 |
| Royalty per unit | ₹1,200 |
| Upfront fee, paid once at signing | ₹15,00,000 |
At the unit level the royalty is modest. The heavy costs sit elsewhere: clinical investigation, testing, tooling and the time to approval. Budget for those first, then negotiate the fee.
What do you need from CDSCO after signing?
A technology licence lets you use the IP and know-how. It does not let you make or sell a medical device. That comes under the Medical Devices Rules, 2017, administered by CDSCO and the state drug controllers.
| Step | Authority | Application form | Licence or permission |
|---|---|---|---|
| Test licence, to make devices for testing and evaluation | CDSCO | MD-12 | MD-13 |
| Manufacturing licence, Class A or B | State Licensing Authority | MD-3 | MD-5 |
| Manufacturing licence, Class C or D | CDSCO (Central Licensing Authority) | MD-7 | MD-9 |
Most of the devices SCTIMST has offered (heart valves, stents, implantable pumps, intracranial electrodes) are likely to sit in the higher risk classes, which means a central licence and, for many, clinical investigation. Check the device's class in CDSCO's published classification lists before you sign, because the class sets both the authority and the evidence you need.
What usually follows an SCTIMST device licence
Common mistakes
- Treating a call as open after its last date. SCTIMST's archives stay online long after the deadlines.
- Sending the EoI by email only, when the call asks for a signed hard copy.
- Underestimating the work left at TRL 4 or 5 for a Class C or D device.
- Signing before checking the status of the patent application and design on IP India's public search.
- Assuming "non-exclusive" is a weakness. For a device with a small market, a non-exclusive licence at a lower fee can be the better deal.
My honest view: SCTIMST is one of the better places in India to source an implantable or cardiac device, because its devices come with real test data. I cannot tell you how long negotiation takes, because the calls do not say, so ask the Technology Business Division at the first meeting.
For the wider process of licensing from public institutes, see licensing technology from Indian institutions. If you want to compare SCTIMST's devices with what other institutes offer, Zernyx Hub has mapped patents from universities across India, with AI business insight on each.
Common questions
How do I apply for a technology from SCTIMST?
Watch the Technologies for Transfer page of SCTIMST's Biomedical Technology Wing for an Expression of Interest call. Fill in Annexures 1, 2 and 3 for the technology you want and send a signed hard copy to the Head, BMT Wing, SCTIMST, Poojapura, Thiruvananthapuram 695012, before the noon deadline stated in the call.
What does an SCTIMST licence cost?
SCTIMST's calls state that technologies are licensed for a combination of an upfront lump-sum fee and annual royalties, and that the terms vary from product to product. The calls do not publish the amounts, so the figures come out of negotiation after your EoI is shortlisted.
Can a startup license a technology from SCTIMST?
Yes. SCTIMST's EoI calls say it offers technologies for licensing to enterprises including startups. The calls we read set no turnover threshold on the page, but you should show the manufacturing, quality and regulatory capability the device needs.
Do I need a CDSCO licence after licensing an SCTIMST device?
Almost always. The licence gives you the right to use the technology, while manufacturing and sale of a medical device need a licence under the Medical Devices Rules, 2017. Class A and B devices are licensed by the State Licensing Authority and Class C and D by CDSCO.